With unclear characteristics of post-infection and post-vaccination immunity. the multiple sclerosis community lacks evidence to guide patients on their continued coronavirus disease 2019 (COVID-19) infection risk. As disease modifying treatments all modulate the immune system. we expect their use to alter acquired immunity to COVID-19. https://yeswellneses.shop/product-category/resveratrol/